MySnackTracker snack-only tracking versus full food tracking
Assessing User Satisfaction and Adherence to an Abbreviated Dietary Tracking App (MySnackTracker) Versus Full-intake Dietary Monitoring
This tests whether a simplified snack-only app (MySnackTracker) helps adults with BMI 28–40 stick with and enjoy diet tracking more than traditional full food logging.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 90 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT06919471 on ClinicalTrials.gov |
What this trial studies
The study compares an abbreviated food-logging approach that records only high-energy, low-nutrient snacks using the MySnackTracker app with standard full-intake dietary monitoring. Participants are adults drawn from specific prior DFI cohorts who have a smartphone, internet access, and a BMI between 28 and 40. Outcomes include adherence to logging, acceptability/satisfaction, and a range of secondary measures such as weight change, dietary intake metrics, self-efficacy scores, and activity questionnaire results. The intervention includes use of the MySnackTracker app and Fitbit monitoring during the study period.
Who should consider this trial
Good fit: Ideal candidates are adults (18+) with BMI 28–40 who previously participated in listed DFI cohorts, can read English, have a smartphone and internet access, and are willing to use the app and Fitbit.
Not a fit: People with BMI below 28 or above 40, pregnant women, those who are cognitively impaired, prisoners, non-English speakers, or those with prior or planned bariatric surgery are not likely to receive benefit from participation.
Why it matters
Potential benefit: If successful, this approach could make dietary self-monitoring easier to maintain and improve long-term adherence and satisfaction with tracking.
How similar studies have performed: Some prior research on simplified or targeted dietary logging has shown improved short-term adherence, but direct comparisons to full-intake monitoring remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Eligibility Criteria In order to be eligible to participate in this study, an participants must meet all of the following criteria: * Provision of signed and dated informed consent form * Access to internet connection, email address, and smartphone able to download the intervention app * Current or previous participation in one of the following DFI cohorts: PA17-0584 (MERIT Study), Project CHURCH, High Risk Breast Cohort, Mexican-American Cohort, and rural cancer survivors from the Mind Your BEAT study * Demonstrated ability to read and understand English. The study app is currently only available in English. Exclusion Criteria An participant who meets any of the following criteria will be excluded from participation in this study: * Prisoners * Anyone currently under 18 years of age * Cognitively impaired participants * Pregnant women (assessed by self-report) * BMI less than 28 or greater than 40 * Self-reported previous or planned bariatric surgery * Self-reported current or planned use of a GLP-1 agonist medication * Self-reported current or planned participation in another weight loss intervention * Cancer participants receiving active treatment * Anyone currently unable to participate in the research for the duration of the study * No current motivation to lose weight
Where this trial is running
Houston, Texas
- MD Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Karen M Basen-Engquist, MD — M.D. Anderson Cancer Center
- Study coordinator: Karen M Basen-Engquist, MD
- Email: kbasenen@mdanderson.org
- Phone: 713-745-3123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.